USDA Clears Iowa, Indiana to Bar Food Stamps for Soda
USDA Secretary Brooke Rollins said at an event in Washington that she signed waivers from the two states, several days after the USDA
Another half a dozen more waiver requests are 'coming down the line,' Rollins said.
The Department of Agriculture has said other states that requested waivers include Arkansas, Colorado, Kansas, Idaho, Utah, and West Virginia.
'We are on track to sign multiples of SNAP waivers to get junk food and sugary drinks out of our food stamp system, and I am so proud,' Rollins said.
She was speaking at a
Related Stories
5/22/2025
5/20/2025
About 42 million Americans, or about 12 percent of the population, receive food stamps, the report notes. The only restrictions in place before the waivers were approved
The commission pointed to research that
About 259,000 Iowa residents and 610,000 Indiana residents receive food stamps, according to the Center on Budget and Policy Priorities.
'Unlike other administrations, we will not be silenced or intimidated by the corporate lobbyists or special interests. And I want this group to do what they have to do,' President Donald Trump told the event. He said later that the waivers would 'stop taxpayer dollars from being used to make our children obese.'
Under past administrations, the USDA has turned down requests for waivers to ban food stamps from being used for soda and other sugary drinks, including a 2011 rejection of a request from New York City.
Iowa and Indiana asked in their requests for clearance to bar SNAP funds from being used for sugary beverages such as soda as well as certain processed foods such as candy.
'Soaring obesity rates have brought our nation and state to a crossroads,' Iowa Gov. Kim Reynolds
Iowa's Health Director, Kelly Garcia, added that 'limiting food benefits to purchase only the foods we know are healthier is a step in the right direction for Iowans.'
Some groups have said they support new restrictions on SNAP. 'In the face of industry opposition, we have long called upon the U.S. Department of Agriculture to use its authority over SNAP to decrease sugary drink consumption,' the American Heart Association
The American Beverage Association, whose members include PepsiCo, has
The steps came as Congress weighs tax legislation that would result in reducing spending on SNAP by $285.7 billion from 2025 to 2034, according to a Congressional Budget Office
'The Republicans' budget will make America hungrier, poorer and sicker,' Rep. Angie Craig (D-Minn.), the top Democrat on the House of Representatives Agriculture Committee,
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Magazine
an hour ago
- Time Magazine
1 in 30 U.S. Teens Identify as Transgender
Nearly 3 million Americans identify as transgender, including one in 30 of those aged 13 to 17, according to a new report. But data on the country's trans community may soon be hard to come by, its authors warned, as the Trump Administration and a number of GOP-led states seek to limit the recognition, and rights, of transgender people. The UCLA Williams Institute has been publishing reports about transgender Americans since 2011, tracking information such as the race, ethnicity, age, regional location, and mental health of transgender individuals. Trans adults and youth make up 1% of Americans aged 13 and older and 3.3% of 13-to 17-year-olds, according to the institute's Wednesday report. Researchers found that younger adults, those aged 18 to 34, were more likely to identify as transgender than their older counterparts, making up more than 50% of the country's transgender population. For its initial 2011 report, the institute relied on just two state-level population surveys. Researchers noted that they have since been able to access broader and higher-quality data through the Centers of Disease Control and Prevention (CDC): To generate the most recent findings, they used data from the CDC 2021-2023 Behavior Risk Factor Surveillance System and 2021 and 2023 Youth Risk Behavior Survey. The report authors noted that the Youth Risk Behavior Survey in particular 'currently provides the best available data for our estimates of the size and characteristics of youth who identify as transgender in the U.S.' But the agency will no longer collect information on transgender people in compliance with President Donald Trump's Executive Order calling for federal recognition of only two biological sexes. Since Trump returned to office in January, information regarding trans people and health resources for LGBTQ+ people has been quietly removed or modified on federal websites. And the Department of Health and Human Services (HHS) has stepped away from its previous practice of supporting gender-affirming-care, in spite of numerous statements from all major medical associations in the U.S., including the American Medical Association and the American Academy of Pediatrics, declaring the care as best practice. In May, HHS called for 'exploratory therapy' or psychotherapy to treat individuals with gender dysphoria instead of the medically recommended care. Multiple states have also sought to restrict access to gender-affirming care, particularly for minors, amid broader global efforts to target such care for trans youth. A June Supreme Court decision upholding a Tennessee state-level ban on gender-affirming-care for youth delivered a heavy blow to the U.S. LGBTQ+ community, permitting similar bans that have been enacted across the country and presenting a significant obstacle to future efforts to challenge restrictions in the courts. Amid the current political climate, the authors of Wednesday's Williams Institute report say they are unsure whether survey respondents will accurately respond to questions regarding their gender identity moving forward. In addition to the uncertain future of data on the U.S. transgender population, they wrote, 'It is also unclear whether individuals' willingness to disclose on surveys that they identify as transgender will remain unchanged in the years to come.' Despite those looming challenges in gathering information, however, the authors noted it is already clear that younger people are more likely to identify as transgender and they anticipate that to continue being true. 'This has implications for institutions in our society, including educational institutions, the U.S. Armed Forces, civilian workplaces, health care settings, and other areas, regarding how to meet the needs of and provide opportunities for current youth and future generations,' they said.
The Hill
2 hours ago
- The Hill
2.8M in US now identify as transgender: Research
Roughly 2.8 million Americans aged 13 and older identify as transgender, accounting for approximately 1 percent of the U.S. population in that age group, according to a new estimate from the Williams Institute, a research organization focused on sexual orientation and gender identity issues. About three-quarters of people who identify as transgender in the U.S. are under 35, according to the report published Wednesday, and 25 percent are between 13 and 17. Williams Institute researchers used data from the Behavioral Risk Factor Surveillance System (BRFSS) and Youth Risk Behavior Surveillance System (YRBSS) — public health surveys administered by the Centers for Disease Control and Prevention (CDC) — and statistical modeling to estimate the population of trans adults and youth in all 50 states and Washington, D.C. About 2.1 million adults identify as transgender, accounting for approximately 0.8 percent of Americans aged 18 and older, according to Wednesday's report. Roughly 3.3 percent of 13 to 17-year-olds in the U.S., or 724,000, identify as transgender. 'Younger generations are more likely to identify as transgender, and we expect that trend to continue,' said Jody Herman, the report's lead author and a senior scholar at the Williams Institute. 'Youth and young adults are more likely to identify as transgender due to a variety of factors, including a greater willingness among younger individuals to disclose that they identify as transgender on surveys.' That finding is consistent with national surveys on LGBTQ identification. In a February Gallup poll, 23.1 percent of Gen Z said they identify as lesbian, gay, bisexual, transgender or 'something other than heterosexual,' compared with 14.2 percent of Millennials and 5.1 percent of Gen X. The Williams Institute, affiliated with the University of California, Los Angeles School of Law, has tracked the number of transgender people in the U.S. since at least 2011. In 2022, the group estimated that 1.6 million Americans identified as transgender. Most transgender people in the U.S. — about 279,000 — live in the South, according to Wednesday's report, consistent with previous years' findings. Around 175,000 transgender Americans live in the West; 156,000 in the Midwest and 114,000 in the Northeast, the Williams Institute found. Of all adults who identify as transgender, 33 percent are transgender women; 34 percent are transgender men and 33 percent are nonbinary, according to Wednesday's report. The group's estimate comes as President Trump's administration works to remove public health datasets and information from federal government websites about transgender people and identities. Affixed at the top of the CDC's webpage for the YRBSS, which the Williams Institute used in its calculation on Wednesday, is an advisory that 'Any information on this page promoting gender ideology is extremely inaccurate and disconnected from the immutable biological reality that there are two sexes, male and female.' 'The Trump Administration rejects gender ideology and condemns the harms it causes to children, by promoting their chemical and surgical mutilation, and to women, by depriving them of their dignity, safety, well-being, and opportunities,' the advisory reads. 'This page does not reflect biological reality and therefore the Administration and this Department rejects it.' Federal health agencies, including the CDC, were ordered to restore online datasets taken down after Trump issued an executive order in January prohibiting the government from promoting 'gender ideology.' Each of the restored webpages leads with notices condemning 'gender ideology.' The White House has also sought to remove questions about gender identity from national surveys on crime victimization and sexual violence. In February, former U.S. Census Bureau Director Robert Santos told NPR that the bureau had moved to strike gender identity questions from several surveys it conducts because of Trump's Jan. 20 order. 'Federal datasets that include questions about sexual orientation and gender identity have provided critical information to researchers, clinicians, policymakers, and the public,' Andrew R. Flores, a distinguished visiting scholar at the Williams Institute and one of the authors of Wednesday's report, said in a statement. 'Removal of these questions from federal surveys — such as the BRFSS and the YRBS — would significantly hinder the ability of researchers to assess the health, experiences, and needs of transgender people in the United States.'
Yahoo
2 hours ago
- Yahoo
Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval
Cash truly is king. On Monday, shares in Novo Nordisk jumped 4% after the drugmaker announced that US customers who pay out-of-pocket will be able to buy its blockbuster diabetes drug Ozempic for less than half the list price. In a year of struggles against copycats, an emboldened chief rival and political pressure over high prices, executives are no doubt hoping the discount will prove a crowning achievement. READ ALSO: SoftBank Acquires a 2% Stake in Embattled Intel and Brokers Chafe Under Abrupt Expansion of Steel, Aluminum Tariffs A Letter from Washington Without insurance, Ozempic can set back US customers roughly $1,350 a month, or enough to rent a one-bedroom apartment in Kansas City (where the local barbecue might have you in need of a GLP-1 prescription). That hefty price tag has led to a bipartisan pushback in Washington, including from President Donald Trump, who sent a letter to Novo last month demanding executives lower prices for their company's treatments. Trump also urged drugmakers to develop direct-to-consumer sales models for their medicines. Americans spent $98 billion out of pocket on prescriptions last year, a 25% cumulative increase over five years, according to IQVIA, while a majority worry that prescription costs are unaffordable, according to KFF polling. Meanwhile, Novo has its own incentives to lower prices. For one, customers flocked to cheaper copycat drugs that exploded in popularity during a multi-year GLP-1 shortage, one that the FDA declared over earlier this year. And the company's chief rival in the GLP-1 space, Mounjaro- and Zepbound-maker Eli Lilly, has been binge-eating market share. Last month, the pressure prompted Novo to slash its sales and profit forecasts, prompting a massive selloff on Wall Street (shares are down 37% this year). On Monday, the company signalled it will defend its turf: Novo said cash-paying Americans can now buy Ozempic for $499 per month through its official website, its patient assistance program, its newly launched direct-to-consumer online pharmacy, or through discount telehealth platform GoodRx. The move follows Novo's decision to halve the price of weight-loss treatment Wegovy in March. Its price reductions follow similar cuts from Eli Lilly, which slashed the prices of both its weight loss and obesity GLP-1 drugs in March. David Ricks, Eli Lilly's CEO, said at the time that about 10% of the 1 million people who bought Zepbound did so from the company's website. MASHing Success: Monday's news came on the heels of a Friday victory for Novo, when Wegovy received FDA approval to treat metabolic dysfunction-associated steatohepatitis (MASH), a liver condition that affects roughly 5% of US adults, potentially opening up a market of millions of new customers. It was the first GLP-1 treatment to be approved for MASH, giving Novo a leg up against its biggest competitor. Rival Lilly, meanwhile, has run trials, inked deals and even made an acquisition earlier this year with an eye to rolling out MASH treatments. This post first appeared on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter.
